Ressources

We report emergency department and inpatient amphetamine-related trends focusing on co-occurring substance use and psychiatric diagnoses at the Centre for Addiction and Mental Health, the largest m

We sought to identify the predictors of crystal methamphetamine initiation or re-initiation among people on OAT, in order to facilitate the development of effective preventive strategies.

This was a within-subjects study using data from 2187 Ohio prison residents who engaged with a digital CBT program to address their methamphetamine use.

We examined whether American psychiatrists’ perceptions of four psychoactive drugs differed from those indicated by their schedules.

This systematic review aims to assess the efficacy of pharmacotherapy for methamphetamine withdrawal, the first comprehensive meta-analysis since 2008.

Cette étude a permis d’analyser un large éventail de blessures et d’intoxications liées à la consommation de cocaïne seule et en combinaison avec d’autres substances au Canada, à l’aide des données

This study examined a wide range of injuries and poisonings related to cocaine only and in combination with other substances in Canada using sentinel surveillance data captured by the electronic Ca

We defined, estimated, and analyzed national polysubstance use patterns among people who misuse opioids (PWMO).

Modafinil was tested for efficacy in facilitating abstinence in cocaine-dependent patients, compared to placebo.

The support needs of family members of individuals using methamphetamine are poorly understood.

This study examines stimulant co-mention trends among PWUO/PTMOUD on social media over multiple years.

People who use methamphetamine concurrently with opioids face an elevated risk of harm.

We aimed to determine whether the risk of psychotic events increases immediately after initiation of methylphenidate treatment or, in the longer term, 1 year after treatment initiation in adolescen

We conducted a systematic review and meta-analysis to evaluate usefulness of an agonist approach as treatment of (psycho)stimulant use disorder (PSUD).

This study aimed to characterize the prevalence of and the factors associated with a perceived decline in the quality of drugs during the COVID-19 pandemic among community-recruited cohorts of PWUD

The study aims were to describe methamphetamine/amphetamine (MA/A) use among patients treated for OUD with buprenorphine/naloxone (BUP-NX) or extended-release naltrexone (XR-NTX), and to explore as